Research on Pulmonary Hypertension Discussed by Researchers at Complutense University Madrid (Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the ...)

Prensa/medios de comunicación

Período6 abr. 2023

Cobertura de los medios

1

Cobertura de los medios

  • NombreResearch on Pulmonary Hypertension Discussed by Researchers at Complutense University Madrid (Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the ...)
    Nombre/canal del medio de comunicaciónNewsRx Hematology Daily
    Fecha6/04/23
    PersonasLuis Oswaldo Izquierdo Villavicencio
Ver todos 1
Ver menos